Suzetrigine is the first non-opioid analgesic – or medication to control pain – of its class to receive federal approval in more than 20 years. Vertex Pharmaceuticals claimed in a press ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx ...

Suzetrigine is the first non-opioid analgesic – or medication to control pain – of its class to receive federal approval in more than 20 years. Vertex Pharmaceuticals claimed in a press release that ...

The drug, called Journavx (suzetrigine) and manufactured by biotech company Vertex Pharmaceuticals, is a non-opioid painkiller, which doesn’t have addictive properties, unlike opioids often used ...

The painkiller, which has a lofty list price of $15.50 per pill, blocks pain signals before they reach the brain, unlike opioids that reduce pain by latching receptors to the brain and create the ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the generic ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

This new drug is a non-opioid analgesic, the first of its kind, designed to treat moderate to severe acute pain in adults. Journavx works by targeting a pain-signaling pathway involving sodium ...

The new drug, called Journavx, is a non-opioid painkiller ... drug will also carry a list price of $15.50 per pill, which is many times more expensive than comparable opioids, often available ...

“A new non-opioid analgesic therapeutic class for acute pain ... said in a statement. Journavx has a list price of $15.50 per pill, which is significantly more expensive than comparable opioids.